ID EVA3_RHISA Reviewed; 86 AA. AC P0C8E8; DT 25-NOV-2008, integrated into UniProtKB/Swiss-Prot. DT 25-NOV-2008, sequence version 1. DT 25-MAY-2022, entry version 25. DE RecName: Full=Evasin-3 {ECO:0000303|PubMed:18678732, ECO:0000303|PubMed:31167786, ECO:0000303|PubMed:31235521}; DE Short=EVA3 {ECO:0000303|PubMed:31167786}; DE Flags: Precursor; OS Rhipicephalus sanguineus (Brown dog tick) (Ixodes sanguineus). OC Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida; Acari; OC Parasitiformes; Ixodida; Ixodoidea; Ixodidae; Rhipicephalinae; OC Rhipicephalus; Rhipicephalus. OX NCBI_TaxID=34632; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF N-TERMINUS, SUBUNIT, AND RP FUNCTION. RC TISSUE=Salivary gland; RX PubMed=18678732; DOI=10.1084/jem.20072689; RA Deruaz M., Frauenschuh A., Alessandri A.L., Dias J.M., Coelho F.M., RA Russo R.C., Ferreira B.R., Graham G.J., Shaw J.P., Wells T.N.C., RA Teixeira M.M., Power C.A., Proudfoot A.E.I.; RT "Ticks produce highly selective chemokine binding proteins with RT antiinflammatory activity."; RL J. Exp. Med. 205:2019-2031(2008). RN [2] {ECO:0007744|PDB:6I31} RP X-RAY CRYSTALLOGRAPHY (1.79 ANGSTROMS) OF 21-86, FUNCTION, AND DISULFIDE RP BONDS. RX PubMed=31167786; DOI=10.1074/jbc.ra119.008817; RA Lee A.W., Deruaz M., Lynch C., Davies G., Singh K., Alenazi Y., RA Eaton J.R.O., Kawamura A., Shaw J., Proudfoot A.E.I., Dias J.M., RA Bhattacharya S.; RT "A knottin scaffold directs the CXC-chemokine-binding specificity of tick RT evasins."; RL J. Biol. Chem. 294:11199-11212(2019). RN [3] {ECO:0007744|PDB:6QJB} RP STRUCTURE BY NMR OF 37-76, FUNCTION, AND DISULFIDE BONDS. RX PubMed=31235521; DOI=10.1074/jbc.ra119.008902; RA Denisov S.S., Ippel J.H., Heinzmann A.C.A., Koenen R.R., Ortega-Gomez A., RA Soehnlein O., Hackeng T.M., Dijkgraaf I.; RT "Tick saliva protein Evasin-3 modulates chemotaxis by disrupting CXCL8 RT interactions with glycosaminoglycans and CXCR2."; RL J. Biol. Chem. 294:12370-12379(2019). CC -!- FUNCTION: Salivary chemokine-binding protein which shows chemokine CC neutralizing activity and binds to host chemokines CXCL1, CXCL2, CXCL3, CC CXCL5, CXCL6 and CXCL8 (PubMed:18678732, PubMed:31167786, CC PubMed:31235521). Binds to CXCL8 with 1:1 stoichiometry CC (PubMed:31235521). Disrupts CXCL8 homodimer formation, disrupts the CC glycosaminoglycan-binding site of CXCL8 and inhibits the interaction of CC CXCL8 with CXCR2 (PubMed:31235521). {ECO:0000269|PubMed:18678732, CC ECO:0000269|PubMed:31167786, ECO:0000269|PubMed:31235521}. CC -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:18678732}. CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}. CC -!- WEB RESOURCE: Name=Protein Spotlight; Note=Hidden powers - Issue 99 of CC November 2008; CC URL="https://web.expasy.org/spotlight/back_issues/099"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR PDB; 6I31; X-ray; 1.79 A; A/B=21-86. DR PDB; 6QJB; NMR; -; A=37-76. DR PDBsum; 6I31; -. DR PDBsum; 6QJB; -. DR AlphaFoldDB; P0C8E8; -. DR BMRB; P0C8E8; -. DR SMR; P0C8E8; -. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell. DR GO; GO:0019958; F:C-X-C chemokine binding; IDA:UniProtKB. DR GO; GO:1900137; P:negative regulation of chemokine activity; IDA:UniProtKB. DR GO; GO:0090074; P:negative regulation of protein homodimerization activity; IDA:UniProtKB. PE 1: Evidence at protein level; KW 3D-structure; Direct protein sequencing; Disulfide bond; Glycoprotein; KW Secreted; Signal. FT SIGNAL 1..20 FT /evidence="ECO:0000269|PubMed:18678732" FT CHAIN 21..86 FT /note="Evasin-3" FT /id="PRO_0000354058" FT CARBOHYD 45 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 76 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 42..57 FT /evidence="ECO:0000269|PubMed:31167786, FT ECO:0000269|PubMed:31235521, ECO:0007744|PDB:6I31, FT ECO:0007744|PDB:6QJB" FT DISULFID 46..59 FT /evidence="ECO:0000269|PubMed:31167786, FT ECO:0000269|PubMed:31235521, ECO:0007744|PDB:6I31, FT ECO:0007744|PDB:6QJB" FT DISULFID 53..70 FT /evidence="ECO:0000269|PubMed:31167786, FT ECO:0000269|PubMed:31235521, ECO:0007744|PDB:6I31, FT ECO:0007744|PDB:6QJB" FT HELIX 34..36 FT /evidence="ECO:0007829|PDB:6I31" FT STRAND 37..47 FT /evidence="ECO:0007829|PDB:6I31" FT TURN 48..50 FT /evidence="ECO:0007829|PDB:6QJB" FT STRAND 58..60 FT /evidence="ECO:0007829|PDB:6I31" FT STRAND 66..75 FT /evidence="ECO:0007829|PDB:6I31" SQ SEQUENCE 86 AA; 9145 MW; 7FD0823DD19450D4 CRC64; MRALLARLLL CVLVVSDSKG LVSTIESRTS GDGADNFDVV SCNKNCTSGQ NECPEGCFCG LLGQNKKGHC YKIIGNLSGE PPVVRR //